Adelman Michael 4
4 · Aptevo Therapeutics Inc. · Filed Mar 19, 2020
Insider Transaction Report
Form 4
Adelman Michael
SVP, Commercial Operations
Transactions
- Award
Stock Option (right to buy)
2020-02-18+134,800→ 134,800 totalExercise: $0.50Exp: 2030-02-17→ Common Stock (134,800 underlying)
Footnotes (1)
- [F1]The option vests in three approximately equal annual installments beginning on February 17, 2021.